Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHKA | P35790 | 1/20 | 0.43 |
| ▸ | CTSL | P07711 | 10/20 | 0.43 |
| ▸ | PADI3 | Q9ULW8 | 1/20 | 0.41 |
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.40 |
| ▸ | TARS1 | P26639 | 1/20 | 0.40 |
| ▸ | YTHDC1 | Q96MU7 | 3/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.39 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.39 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20974433 | 0.95 | PADI3 (0.47) | CHKACTSLPADI3PADI4CTSB | |
| SCHEMBL19575483 | 0.94 | CHKA (0.43) | CHKACTSLPADI3PADI4CTSB | |
| SCHEMBL19575538 | 0.93 | CHKA (0.42) | CHKACTSLPADI3PADI4CTSB | |
| SCHEMBL20975224 | 0.92 | CTSL (0.47) | CHKACTSLCTSBYTHDC1 | |
| SCHEMBL26218276 | 0.90 | CTSL (0.43) | CHKACTSLCTSBTARS1HDAC1 | |
| SCHEMBL20974863 | 0.90 | YTHDC1 (0.46) | CHKACTSLCTSBYTHDC1 | |
| SCHEMBL20975222 | 0.90 | CTSL (0.48) | CHKACTSLPADI3PADI4CTSB | |
| SCHEMBL19575672 | 0.89 | CHKA (0.46) | CHKACTSLYTHDC1HDAC1HDAC3 | |
| SCHEMBL19574919 | 0.89 | HDAC1 (0.46) | CHKAYTHDC1HDAC1HDAC3HDAC4 | |
| SCHEMBL20975145 | 0.89 | CTSL (0.48) | CHKACTSLPADI3PADI4CTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3452477-B1 | ADENINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | B C I PHARMA (BE) | 2023-09-13 | — | — | EP | disclosed |
| US-11236093-B2 | Adenine derivatives as protein kinase inhibitors | B.C.I. PHARMA (BE) | 2022-02-01 | — | — | US | disclosed |
| US-20190127379-A1 | ADENINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | B.C.I. PHARMA (BE) | 2019-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11236093-B2 | Adenine derivatives as protein kinase inhibitors | ADK, TNNI3K, TNK2 | CHKA 395/4885CTSL 4183/4885PADI3 1045/4885 |
| US-20190127379-A1 | ADENINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | ADK, TNNI3K, TNK2 | CHKA 395/4885CTSL 4183/4885PADI3 1045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.